Lecture Delivery & Question | GENDER | MEAN RANK | p-value | CLINICAL TRAINING | MEAN RANK | p-value |
---|---|---|---|---|---|---|
Rec SAQ | Females | 124.81 | 0.049 | Preclinical | 125.02 | 0.165 |
Males | 106.83 | Clinical | 112.62 | |||
F2F SAQ | Females | 113.5 | 0.567 | Preclinical | 133.05 | < 0.001 |
Males | 108.46 | Clinical | 93.84 | |||
CK-REC SAQ | Females | 92.27 | 0.032 | Preclinical | 72.08 | 0.003 |
Males | 75.52 | Clinical | 95.19 | |||
CK-F2F SAQ | Females | 82.96 | 0.316 | Preclinical | 83.28 | 0.448 |
Males | 75.49 | Clinical | 77.67 | |||
AK-REC SAQ | Females | 89.97 | 0.175 | Preclinical | 86.62 | 0.894 |
Males | 79.36 | Clinical | 85.59 | |||
AK-F2F SAQ | Females | 80.51 | 0.863 | Preclinical | 78.33 | 0.7 |
Males | 79.22 | Clinical | 81.18 | |||
Rec MCQ | Females | 8.79 | 0.684 | Preclinical | N/A | |
Males | 7.63 | Clinical | ||||
F2F MCQ | Females | 8.96 | 0.521 | Preclinical | N/A | |
Males | 7.13 | Clinical | ||||
CK-REC MCQ | Females | 8.75 | 0.77 | Preclinical | N/A | |
Males | 7.75 | Clinical | ||||
CK-F2F MCQ | Females | 8.83 | 0.684 | Preclinical | N/A | |
Males | 7.50 | Clinical | ||||
AK-REC MCQ | Females | 9.08 | 0.446 | Preclinical | N/A | |
Males | 6.75 | Clinical | ||||
AK-F2F MCQ | Females | 8.67 | 0.862 | Preclinical | N/A | |
Males | 8.00 | Clinical |